D-0260-2025 Class II Ongoing

Recalled by Aspen Biopharma Labs Pvt., Ltd. — Medchal Malkajgiri

FDA drug recall D-0260-2025 was initiated by Aspen Biopharma Labs Pvt., Ltd. on Feb 7, 2025 and is designated Class II. Reason for recall: CGMP Deviations The recall status is ongoing. Affected quantity: 400.0 gm.

Recall details

Product Type
Drugs
Report Date
Mar 19, 2025
Initiation Date
Feb 7, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
400.0 gm

Product description

Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.

Reason for recall

CGMP Deviations

Distribution pattern

Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)

Code information

Lot Numbers: HABTC0020123, exp. date Dec-2026 HABTC0050623, exp. date May-2027 HABTC0091023, exp. date Sep-2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0260-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0260-2025. Report a data issue: hello@regdatalab.com.